Vasopressin and Autism

New research indicates that low levels of vasopressin in cerebrospinal fluid may serve as a potential biomarker for autism risk, suggesting a link between vasopressin and social cognition deficits. Ongoing studies aim to explore whether individuals with autism produce less vasopressin or if other factors are at play. The implications of these findings could significantly impact clinical referral and risk management strategies.